Cargando…

Repurposing cancer drugs to treat neurological diseases – Src inhibitors as examples

Detalles Bibliográficos
Autor principal:	Liu, Da Zhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514862/ https://www.ncbi.nlm.nih.gov/pubmed/28761420 http://dx.doi.org/10.4103/1673-5374.208569

Ejemplares similares

Repurposing drugs to treat neurological diseases
por: Massey, T. H., et al.
Publicado: (2018)

Repurposing niclosamide for the treatment of neurological disorders
por: Apolloni, Savina, et al.
Publicado: (2023)

Antifungal Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2020)

Drug repurposing for neuroregeneration in multiple sclerosis
por: Küry, Patrick, et al.
Publicado: (2018)

Multiple sclerosis drug repurposing for neuroregeneration
por: Göttle, Peter, et al.
Publicado: (2023)

Multi-targeted anti-inflammatory drugs for the treatment of neurological disorders
por: Lui, Austin, et al.
Publicado: (2022)

Old Weapon for New Enemy: Drug Repurposing for Treatment of Newly Emerging Viral Diseases
por: Guo, Deyin
Publicado: (2020)

Can Any Drug Be Repurposed for Cancer Treatment? A Systematic Assessment of the Scientific Literature
por: Stransky, Nicolai, et al.
Publicado: (2021)

Drug combination and repurposing for cancer therapy: the example of breast cancer
por: Correia, Ana Salomé, et al.
Publicado: (2021)

Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study
por: Desai, Rishi J., et al.
Publicado: (2020)

Advancements in Drug Repurposing: Examples in Psychiatric Medications
por: Okuyama, Ryo
Publicado: (2023)

A Multi-Objective Approach for Anti-Osteosarcoma Cancer Agents Discovery through Drug Repurposing
por: Cabrera-Andrade, Alejandro, et al.
Publicado: (2020)

Repositioning canakinumab for non-small cell lung cancer—important lessons for drug repurposing in oncology
por: Lythgoe, Mark P., et al.
Publicado: (2022)

Anti-COVID drugs: repurposing existing drugs or search for new complex entities, strategies and perspectives
por: Pawełczyk, Anna, et al.
Publicado: (2020)

SRC-2 Coactivator: a role in human metabolic evolution and disease
por: O’Malley, Bert W.
Publicado: (2020)

National drug policy reform for noncommunicable diseases in low-resource countries: an example from Bangladesh
por: Islam, Sheikh Mohammed Shariful, et al.
Publicado: (2017)

Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2
por: Lisi, Lucia, et al.
Publicado: (2020)

Repurposing verapamil for prevention of cognitive decline in sporadic Alzheimer's disease
por: Ahmed, Heba A., et al.
Publicado: (2021)

Repurposing of α1-Adrenoceptor Antagonists: Impact in Renal Cancer
por: Mihalopoulos, Meredith, et al.
Publicado: (2020)

Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?
por: Lord, Simon R., et al.
Publicado: (2023)

Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates
por: Rodrigues, Liliana, et al.
Publicado: (2022)

Repurposing ibrutinib: therapeutic effects and implications for translational approaches in Alzheimer’s disease
por: Lee, Hyun-ju, et al.
Publicado: (2023)

OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs
por: Kast, Richard E., et al.
Publicado: (2021)

Progress in mimicking brain microenvironments to understand and treat neurological disorders
por: Ngo, Mai T., et al.
Publicado: (2021)

Targeting the Src N-terminal regulatory element in cancer
por: Mezquita, Betlem, et al.
Publicado: (2023)

Metastasis, an Example of Evolvability
por: Laruelle, Annick, et al.
Publicado: (2021)

Challenges and perspective of drug repurposing strategies in early phase clinical trials
por: Kato, Shumei, et al.
Publicado: (2015)

Repurposing Statins for Renal Protection: Is It a Class Effect?
por: McWilliam, Stephen J., et al.
Publicado: (2017)

A New Requirement for Publication: Access to Effective Drugs for Ethical Reasons, The Example of Heart Failure
por: Roubille, François, et al.
Publicado: (2021)

Proteolytic inhibitors as alternative medicines to treat trypanosomatid-caused diseases: experience with calpain inhibitors
por: Ennes-Vidal, Vítor, et al.
Publicado: (2022)

Programmable macromolecule-based RNA-targeting therapies to treat human neurological disorders
por: Morelli, Kathryn H., et al.
Publicado: (2023)

Recent advances in RNA-targeting therapy for neurological diseases
por: Kumar, Satheesh, et al.
Publicado: (2023)

Transcranial electrical stimulation in neurological disease
por: Brown, Gregory L., et al.
Publicado: (2022)

Repurposing Quaternary Ammonium Compounds as Potential Treatments for COVID-19
por: Baker, Nancy, et al.
Publicado: (2020)

Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen
por: Kast, Richard E, et al.
Publicado: (2017)

The role of SRC-3 in estrogen-dependent vasoprotection during vascular wall remodeling postinjury
por: Xu, Jianming
Publicado: (2003)

Verapamil, a possible repurposed therapeutic candidate for stroke under hyperglycemia
por: Ismael, Saifudeen, et al.
Publicado: (2022)

Agriculture Waste Biomass Repurposed into Natural Fibers: A Circular Bioeconomy Perspective
por: Jayaprakash, Kuzhandaivel, et al.
Publicado: (2022)

Pharmacological inhibition of cation-chloride cotransporters for neurological diseases
por: Nepomuceno, Rachel, et al.
Publicado: (2015)

Biomarker-guided drug therapy: personalized medicine for treating Alzheimer’s disease
por: Syal, Charvi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_paq3gcvg3nrf068hu2cgnn6092